When to start antiretroviral therapy: the need for an evidence base during early HIV infection

BACKGROUND: Strategies for use of antiretroviral therapy (ART) have traditionally focused on providing treatment to persons who stand to benefit immediately from initiating the therapy. There is global consensus that any HIV+ person with CD4 counts less than 350 cells/μl should initiate ART. However...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lundgren, Jens D, Babiker, Abdel G, Gordin, Fred M, Borges, Álvaro H, Neaton, James D
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Debate
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682886/
https://ncbi.nlm.nih.gov/pubmed/23767777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-11-148
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky